Clover Health Investments, Corp. (CLOV) - Stock Analysis
Last updated: Jun 21, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profitability Rebound ⢠Strong Cash Flow ⢠Balance Sheet Risk CLOV showed a sharp turnaround to profitability and positive cash flow with strong liquidity and no debt, but rising liabilities, a large retained-earnings deficit, stock-based dilution, and a still-rich valuation temper the outlook.
Price Behavior
Key Price Behavior Insights: ⢠Higher highs ⢠Shallow pullbacks ⢠Stretch risk Support Level: $4.73-$4.80 Resistance Level: $5.00 CLOV has surged over the last month in a steady uptrend, but after a fast move to $5.00 it looks extended and needs to hold $4.73â$4.80 to confirm the breakout.
Sentiment & News
Key News Insights: ⢠Star Rating boost ⢠Insider share sale ⢠Regulatory catalyst Clover Health jumped as a court-ordered CMS ruling lifted its PPO Medicare Star Rating to 4.5 stars, outweighing a large insider share sale signal.
AI Summary
CLOV has moved from a âpossible turnaroundâ to a credible profit-and-cash-generation story, driven by rapid Medicare Advantage membership growth and a 4.5-star PPO upgrade, but the key investment question now is whether improved margins, cash flow, and underwriting can persist through regulatory, medical-cost, and execution risks after the stock's sharp run-up.
Description
Clover Health Investments, Corp. is a U.S. insurer that offers Medicare Advantage products to eligible beneficiaries, delivering plan administration through its Clover Assistant software platform and operating both PPO and HMO plan types. The company also conducts non-insurance activities alongside its core insurance business. Founded in 2014, Clover Health is headquartered in Franklin, Tennessee.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| May 7 | May 14 | CLOV | Clover Health Investments, Corp. | Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside. | Closed | +23.8% |